Ifp Advisors, Inc Accelerate Diagnostics, Inc Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.51 - $17.1 $102 - $3,420	-200 Reduced 75.47%	65 $1,000
Q2 2022 Sep 06, 2022	BUY	$0.54 - $1.41 $143 - $373	265 New	265 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.54 - $1.41 $143 - $373	-265 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.4 - $5.15 $350 - $1,287	250 Added 1666.67%	265 $0
Q4 2021 Jan 12, 2022	BUY	$4.27 - $6.97 $64 - $104	15 New	15 $1,000
Q4 2019 Jan 17, 2020	SELL	$14.6 - $18.13 $2,920 - $3,626	-200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $2,352 - $4,430	200 New	200 $4,000
Q4 2017 Jan 24, 2018	SELL	$18.0 - $30.0 $2,970 - $4,950	-165 Closed	0 $0
Q2 2017 Jun 03, 2019	BUY	N/A	100 Added 153.85%	165 $5,000
Q4 2016 Jun 03, 2019	SELL	N/A	-135 Reduced 67.5%	65 $1,000
Q1 2016 Jun 03, 2019	BUY	N/A	200	200 $4,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.